Biotech Across
America Roadshow
Reports from the Road
For 18 months, the NSCEB traveled the country highlighting the people, organizations, and ideas shaping the future of U.S. biotech. After visiting 34 states, one takeaway is clear: regional biotech ecosystems are linked by common challenges and opportunities, and while the future is bright, policy decisions made in Washington today will determine whether each state can reach its full potential.
34
States an Territories
54
Cities and Towns
56,000+
Miles
Who was there?
700+
Organizations
79
Congressional offices
56
State and Local officials
140+
State Symposium attendees
Loading...
Loading...
Fun Facts
89
Lab tours
15
Biomanufacturing facility tours
116
Memos written
3
Tornadoes
60+
Hotel breakfasts
Policy Themes
01
Workforce Development and Education
The educational programs and training pipelines needed to develop a strong U.S. biotechnology workforce
02
Commercialization Pipeline
The challenges and solutions to bringing new biotechnology products from the lab to the commercial market
03
Partnerships
Initiatives and projects that bring together stakeholders from different parts of the biotechnology industry, including from the public sector
04
Start-Up Challenges
Barriers to market entry faced by start-ups and small companies trying to move from early-stage development to commercial viability
05
Biomanufacturing
The specific infrastructure needed to produce biotechnology products at commercial scale
06
Access to Capital
The investments needed for U.S. biotechnology companies to innovate and grow here at home
07
Regulatory Hurdles
The often slow and duplicative system that biotechnology companies must navigate to get products approved for the U.S. market
08
Bioliteracy
The programs and initiatives developing greater fluency in biology and biotechnology across communities
